134 related articles for article (PubMed ID: 6720960)
1. Structural prerequisites for the hypotensive action of parathyroid hormone.
Ellison DH; McCarron DA
Am J Physiol; 1984 May; 246(5 Pt 2):F551-6. PubMed ID: 6720960
[TBL] [Abstract][Full Text] [Related]
2. Effects of synthetic analogs and fragments of bovine parathyroid hormone on adenosine 3',5'-monophosphate level, ornithine decarboxylase activity, and glycosaminoglycan synthesis in rabbit costal chondrocytes in culture: structure-activity relations.
Takano T; Takigawa M; Shirai E; Suzuki F; Rosenblatt M
Endocrinology; 1985 Jun; 116(6):2536-42. PubMed ID: 2986953
[TBL] [Abstract][Full Text] [Related]
3. Cardiac actions and structural--activity relationship of parathyroid hormone on isolated frog atrium.
Sham JS; Kenny AD; Pang PK
Gen Comp Endocrinol; 1984 Sep; 55(3):373-7. PubMed ID: 6332042
[TBL] [Abstract][Full Text] [Related]
4. A multiresponse parathyroid hormone assay: an inhibitor has agonist properties in vivo.
Horiuchi N; Rosenblatt M; Keutmann HT; Potts JT; Holick MF
Am J Physiol; 1983 Jun; 244(6):E589-95. PubMed ID: 6305202
[TBL] [Abstract][Full Text] [Related]
5. Effects of bPTH fragments (1-34), (3-34) and (7-34) on uterine contraction.
Shew RL; Pang PK
Peptides; 1984; 5(3):485-8. PubMed ID: 6473169
[TBL] [Abstract][Full Text] [Related]
6. Effects of parathyroid hormone and the synthetic 1-34 amino-terminal fragment in rats and dogs.
Stevenson RW; Parsons JA
J Endocrinol; 1983 Apr; 97(1):21-30. PubMed ID: 6842124
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of [Tyr34]bPTH-(7-34)-amide on bPTH-(1-34) ability to reduce uterine contraction.
Shew RL; Robinson MF; Olansky L; Yee JA
Pharmacology; 1989; 39(6):390-6. PubMed ID: 2634857
[TBL] [Abstract][Full Text] [Related]
8. Binding of intact parathyroid hormone to rat osteosarcoma cells: major contribution of binding sites for the carboxyl-terminal region of the hormone.
Rao LG; Murray TM
Endocrinology; 1985 Oct; 117(4):1632-8. PubMed ID: 2992916
[TBL] [Abstract][Full Text] [Related]
9. Structure activity relationship of parathyroid hormone: separation of the hypotensive and the hypercalcemic properties.
Pang PK; Yang MC; Keutmann HT; Kenny AD
Endocrinology; 1983 Jan; 112(1):284-9. PubMed ID: 6847823
[TBL] [Abstract][Full Text] [Related]
10. Evaluation in vivo of a potent parathyroid hormone antagonist: [Nle8,18,D-Trp12,Tyr34]bPTH(7-34)NH2.
Dresner-Pollak R; Yang QM; Behar V; Nakamoto C; Chorev M; Rosenblatt M
J Bone Miner Res; 1996 Aug; 11(8):1061-5. PubMed ID: 8854241
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone stimulates adenylate cyclase in rat cerebral microvessels.
Huang M; Hanley DA; Rorstad OP
Life Sci; 1983 Feb; 32(9):1009-14. PubMed ID: 6827919
[TBL] [Abstract][Full Text] [Related]
12. Uterine relaxing action of parathyroid hormone: effect of oxidation and methionine substitution.
Shew RL; Kenny AD; Pang PK
Proc Soc Exp Biol Med; 1984 Apr; 175(4):444-8. PubMed ID: 6709644
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase-A and the effects of parathyroid hormone on phosphate uptake in opossum kidney cells.
Martin KJ; McConkey CL; Garcia JC; Montani D; Betts CR
Endocrinology; 1989 Jul; 125(1):295-301. PubMed ID: 2544405
[TBL] [Abstract][Full Text] [Related]
14. Effects of synthetic bovine parathyroid hormone (1-34) and its analogues on 45Ca uptake and adenylate cyclase activation in bone and plasma calcium levels in the chick.
Dacke CG; Shaw AJ
Q J Exp Physiol; 1988 Jul; 73(4):573-84. PubMed ID: 3174916
[TBL] [Abstract][Full Text] [Related]
15. The arterio-venous difference for immunoreactive parathyroid hormone and the production of adenosine 3,'5'-monophosphate by isolated perfused bone: studies with analogs of parathyroid hormone.
Martin KJ; Bellorin-Font E; Freitag J; Rosenblatt M; Slatopolsky E
Endocrinology; 1981 Sep; 109(3):956-9. PubMed ID: 6266817
[TBL] [Abstract][Full Text] [Related]
16. Sulfur-free parathyroid hormone analogues containing D-amino acids: biological properties in vitro and in vivo.
Rosenblatt M; Coltrera MD; Shepard GL; Gray DA; Parsons JA; Potts JT
Biochemistry; 1981 Dec; 20(25):7246-50. PubMed ID: 6274393
[TBL] [Abstract][Full Text] [Related]
17. Rapid development of renal resistance to low doses of synthetic bovine parathyroid hormone fragment 1-34. Dissociation of urinary cyclic adenosine monophosphate, phosphaturic, and calciuric responses.
Law WM; Heath H
J Clin Invest; 1983 Sep; 72(3):1106-13. PubMed ID: 6309905
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of bPTH(1-34) and its analogue Nle8,18Tyr34bPTH(3-34) amide.
Daugirdas JT; Al-Kudsi RR; Ing TS; Yang MC; Leehey DJ; Pang PK
Miner Electrolyte Metab; 1987; 13(1):33-7. PubMed ID: 3587182
[TBL] [Abstract][Full Text] [Related]
19. Parathyroid hormone (PTH)-(1-34), [Nle(8,18),Tyr34]PTH-(3-34) amide, PTH-(1-31) amide, and PTH-related peptide-(1-34) stimulate phosphatidylcholine hydrolysis in UMR-106 osteoblastic cells: comparison with effects of phorbol 12,13-dibutyrate.
Singh AT; Kunnel JG; Strieleman PJ; Stern PH
Endocrinology; 1999 Jan; 140(1):131-7. PubMed ID: 9886817
[TBL] [Abstract][Full Text] [Related]
20. Structure and vascular activity relationship of parathyroid hormone and some hypotensive peptides.
Pang PK; Yang MC; Kenny AD; Tenner TE
Clin Exp Hypertens A; 1982; 4(1-2):189-99. PubMed ID: 7074985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
